MIRIKIZUMAB-INDUCED TRANSCRIPTOME CHANGES IN PATIENT BIOPSIES AT WEEK 12 ARE MAINTAINED THROUGH WEEK 52 IN PATIENTS WITH ULCERATIVE COLITIS
Venkatesh Krishnan 1
1 Eli Lilly and Company
Topic
Disease Mechanisms, IBD
Session
IBD: Clinical trials poster I
Conference
UEG Week Virtual 2021
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing